108 related articles for article (PubMed ID: 2610006)
1. The effect and distribution of a protein-bound polysaccharide preparation, PSK (Krestin), intratumorally injected prior to surgery into gastric cancer patients.
Tomochika H; Gouchi A; Okanobu K; Sasaki A; Fuchimoto S; Orita K
Acta Med Okayama; 1989 Oct; 43(5):289-97. PubMed ID: 2610006
[TBL] [Abstract][Full Text] [Related]
2. Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection.
Kondo T; Sakamoto J; Nakazato H
Biotherapy; 1991; 3(4):287-95. PubMed ID: 1786194
[TBL] [Abstract][Full Text] [Related]
3. [Differences of antitumor effect of various BRMs by intratumoral administration].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1429-32. PubMed ID: 1530288
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer.
Nio Y; Tsubono M; Tseng CC; Morimoto H; Kawabata K; Masai Y; Shiraishi T; Imai S; Ohgaki K; Tobe T
Biotherapy; 1992; 4(2):117-28. PubMed ID: 1622733
[TBL] [Abstract][Full Text] [Related]
5. [S-1/krestin immunochemotherapy for patients with advanced gastric cancer].
Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A; Rino Y; Masuda M
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1921-3. PubMed ID: 22202239
[TBL] [Abstract][Full Text] [Related]
6. [Differences in antitumor effect of various BRMs by intratumoral administration: induction of immunosuppressive acidic protein].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1453-6. PubMed ID: 8373204
[TBL] [Abstract][Full Text] [Related]
7. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
[TBL] [Abstract][Full Text] [Related]
8. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M; Yang LX
Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
[TBL] [Abstract][Full Text] [Related]
9. In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer.
Sugimachi K; Maehara Y; Kusumoto T; Okamura T; Korenaga D; Kohnoe S; Baba H; Anai H
Anticancer Res; 1995; 15(5B):2175-9. PubMed ID: 8572620
[TBL] [Abstract][Full Text] [Related]
10. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
Ichihashi H; Kondo T; Nakazato H
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor effect of intratumoral administration of a Coriolus preparation, PSK: inhibition of tumor invasion in vitro].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2241-3. PubMed ID: 7944450
[TBL] [Abstract][Full Text] [Related]
12. [Ten cases of advanced gastro-intestinal cancer that required preoperative dosage of PSK].
Ooshiro M; Kitahara T; Takagi R; Moriyama A; Urita T; Yoshida Y; Tanaka H; Nihonyanagi Y; Sugishita Y; Oshiro T; Kinoshita T; Nagashima M; Park Y; Okazumi S; Katoh R
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1967-8. PubMed ID: 20037293
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor effect of PSK (1). Interferon-inducing activity and intratumoral administration].
Ebina T; Kohya H; Inoue H; Aso H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1841-6. PubMed ID: 2439019
[TBL] [Abstract][Full Text] [Related]
14. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682
[TBL] [Abstract][Full Text] [Related]
15. [Regional adoptive immunotherapy using activated lymphocytes].
Ebina T; Isono N; Murata K; Yokoyama J; Mikuni J; Ohuchi K
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1549-52. PubMed ID: 8854802
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation.
Ebina T; Kohya H
Jpn J Cancer Res; 1988 Aug; 79(8):957-64. PubMed ID: 3141330
[TBL] [Abstract][Full Text] [Related]
17. Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Saji S; Sakamoto J; Teramukai S; Kunieda K; Sugiyama Y; Ohashi Y; Nakazato H
Surg Today; 1999; 29(6):504-10. PubMed ID: 10385364
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors.
Algarra I; Collado A; Garcia Lora A; Garrido F
J Exp Clin Cancer Res; 1999 Mar; 18(1):39-46. PubMed ID: 10374675
[TBL] [Abstract][Full Text] [Related]
19. Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.
Maehara Y; Inutsuka S; Takeuchi H; Baba H; Kusumoto H; Sugimachi K
Cancer Chemother Pharmacol; 1993; 33(2):171-5. PubMed ID: 8261578
[TBL] [Abstract][Full Text] [Related]
20. Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin).
Ikuzawa M; Matsunaga K; Nishiyama S; Nakajima S; Kobayashi Y; Andoh T; Kobayashi A; Ohhara M; Ohmura Y; Wada T
Int J Immunopharmacol; 1988; 10(4):415-23. PubMed ID: 3170055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
